The cost of the two planned phase II clinical trials was outlined in the recent investor presentation one was US$750,000 and the other US$710,000 which is a fair chunk of the remaining funds. Hopefully by then the income is starting to stream in. You never know Slogobov might be close to signing some major Satipharm pill deal.
- Forums
- ASX - By Stock
- Ann: Quarterly Update and Appendix 4C-MMJ.AX
The cost of the two planned phase II clinical trials was...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add HGV (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.001(2.00%) |
Mkt cap ! $10.72M |
Open | High | Low | Value | Volume |
5.1¢ | 5.1¢ | 5.1¢ | $11.47K | 225K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 154010 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 36667 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 154010 | 0.051 |
1 | 51011 | 0.050 |
1 | 75000 | 0.048 |
1 | 1000000 | 0.047 |
1 | 250000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 36667 | 2 |
0.055 | 129870 | 1 |
0.057 | 16111 | 1 |
0.058 | 45081 | 3 |
0.060 | 31852 | 2 |
Last trade - 11.41am 04/10/2024 (20 minute delay) ? |
Featured News
HGV (ASX) Chart |